- Publication of the Month
- Ask The Expert
- MPO Research
- MPO News
- Information Signup
 
  - LEE BioSolutions
- Applichem
 


Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
Author: L. Zheng, B. Nukuna, M. Brennan, M. Sun, M. Goormastic, M. Settle, D. Schmitt, X. Fu, L. Thomson, P.L. Fox, H. Ischiropoulos, J.D. Smith, M. Kinter, and S.L. Hazen
Study shows that apoA-I is selective target for MPO-catalyzed nitration and chlorination in vivo and that MPO-catalyzed oxidation of HDL and apoA-I results in selective inhibition in ABCA1-dependent cholesterol efflux from macrophages.
 
<< Back
  HOME TERMS OF USE PRIVACY POLICY COPYRIGHT NOTICE CONTACT US